Hemostasis Today

August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Aurelio Maggio: New Perspectives in The Treatment of Paroxysmal Nocturnal Hemoglobinuria
Aug 27, 2026, 16:26

Aurelio Maggio: New Perspectives in The Treatment of Paroxysmal Nocturnal Hemoglobinuria

Aurelio Maggio, President of Foundation Franco and Piera Cutino at Foundation Franco and Piera Cutino, shared Global Hematological Rare Diseases Allianc’s post on LinkedIn, adding:

“New perspectives in the treatment of paroxysmal nocturnal hemoglobinuria (PNH).

I am pleased to share this new GARDEN Experts Insights contribution by Prof. Elena Solomou, exploring how innovative complement-targeted therapies are reshaping PNH management and opening the way toward increasingly personalized treatment strategies.”

GARDEN, Global Hematological Rare Diseases Alliance, shared a post on LinkedIn about a recent article by Elena Solomou, published in GARDEN, adding:

“How is innovation reshaping the treatment of paroxysmal nocturnal hemoglobinuria (PNH)?

In this new contribution from the GARDEN Experts Insights series, Prof. Elena Solomou explores the rapidly evolving therapeutic landscape of PNH, from established C5 inhibition to next-generation complement-targeted therapies.

Drawing on current clinical evidence, she discusses how proximal complement inhibitors, oral therapies, and combination strategies are expanding treatment options, with the aim of achieving more complete disease control, reducing residual anemia and treatment burden, and moving toward a more personalized approach to PNH care.

A valuable expert perspective on how therapeutic innovation is changing the management and long-term outlook of patients living with PNH.”

Title: Current and Ongoing Innovative Treatments in Paroxysmal Nocturnal Hemoglobinuria

Author: Elena Solomou

Aurelio Maggio: New Perspectives in The Treatment of Paroxysmal Nocturnal Hemoglobinuria

Stay updated on all scientific advances with Hemostasis Today.